Literature DB >> 24390465

Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program.

E Susan Amirian1, J Clay Goodman, Pamela New, Michael E Scheurer.   

Abstract

Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue sarcomas that arise predominantly from Schwann cells. Despite the fact that MPNSTs have high local recurrence rates and are generally associated with poor prognosis, little is known about prognostic factors or effective clinical management for this tumor type. The purpose of this study was to describe the distributions of patient and tumor characteristics and to identify predictors of cause-specific survival among MPNST cases reported to SEER between 1973 and 2008. Patient and tumor characteristics were compared between pediatric and adult MPNST cases. Cox regression and tree-based survival analysis were used to examine factors associated with MPNST-related mortality separately among adults and children. A total of 1,315 MPNST cases were isolated from the 1973-2008 SEER dataset. Among pediatric cases, sex, race, and radiation therapy predicted MPNST survival, whereas among adults, tumor site, tumor grade, number of primary tumors, and tumor size were significant predictors. As tumor size at diagnosis/resection may be the only somewhat "modifiable" prognostic factor, future studies should aim to identify biological and social attributes associated with tumor size at diagnosis, separately among individuals with and without NF-1, in order to help identify earlier opportunities for clinical intervention.

Entities:  

Mesh:

Year:  2014        PMID: 24390465     DOI: 10.1007/s11060-013-1345-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  34 in total

Review 1.  Peripheral and cranial nerve sheath tumors.

Authors:  Maciej M Mrugala; Tracy T Batchelor; Scott R Plotkin
Journal:  Curr Opin Neurol       Date:  2005-10       Impact factor: 5.710

2.  Relative risk trees for censored survival data.

Authors:  M LeBlanc; J Crowley
Journal:  Biometrics       Date:  1992-06       Impact factor: 2.571

3.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

Review 4.  Diagnosis and treatment options for nerve sheath tumors.

Authors:  Jason H Huang; Jun Zhang; Eric L Zager
Journal:  Expert Rev Neurother       Date:  2005-07       Impact factor: 4.618

5.  Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases.

Authors:  J E Wanebo; J M Malik; S R VandenBerg; H J Wanebo; N Driesen; J A Persing
Journal:  Cancer       Date:  1993-02-15       Impact factor: 6.860

Review 6.  Management of childhood malignant peripheral nerve sheath tumor.

Authors:  Andrea Ferrari; Gianni Bisogno; Modesto Carli
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Neurogenic sarcomas: experience at the University of Toronto.

Authors:  L Angelov; A Davis; B O'Sullivan; R Bell; A Guha
Journal:  Neurosurgery       Date:  1998-07       Impact factor: 4.654

8.  Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.

Authors:  Changye Zou; Kerrington D Smith; Jun Liu; Guy Lahat; Sarah Myers; Wei-Lien Wang; Wei Zhang; Ian E McCutcheon; John M Slopis; Alexander J Lazar; Raphael E Pollock; Dina Lev
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

Review 9.  Pediatric neurofibrosarcoma.

Authors:  Holly Neville; Cyndy Corpron; Martin L Blakely; Richard Andrassy
Journal:  J Pediatr Surg       Date:  2003-03       Impact factor: 2.545

Review 10.  Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.

Authors:  Matthias Kolberg; Maren Høland; Trude H Agesen; Helge R Brekke; Knut Liestøl; Kirsten S Hall; Fredrik Mertens; Piero Picci; Sigbjørn Smeland; Ragnhild A Lothe
Journal:  Neuro Oncol       Date:  2012-11-15       Impact factor: 12.300

View more
  15 in total

1.  Pediatric peripheral nerve tumors: clinical and surgical aspects.

Authors:  Fernando Guedes; Rosana Siqueira Brown; Francisco José Lourenço Torrão-Junior; Daniel A N Barbosa; Guilherme de Andrade Gagheggi Ravanini; Rogério Martin Pires Amorim
Journal:  Childs Nerv Syst       Date:  2019-07-25       Impact factor: 1.475

2.  Racial/ethnic disparities and incidence of malignant peripheral nerve sheath tumors: results from the Surveillance, Epidemiology, and End Results Program, 2000-2014.

Authors:  Erin C Peckham-Gregory; Roberto E Montenegro; David A Stevenson; David H Viskochil; Michael E Scheurer; Philip J Lupo; Joshua D Schiffman
Journal:  J Neurooncol       Date:  2018-04-16       Impact factor: 4.130

3.  The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology, and End Results-Based Analysis.

Authors:  Allison M Domingues; Christopher L Moertel; Erin L Marcotte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-09-02       Impact factor: 4.090

Review 4.  What MRI can tell us about neurogenic tumors and rhabdomyosarcoma.

Authors:  M Beth McCarville
Journal:  Pediatr Radiol       Date:  2016-05-26

Review 5.  Immune profiling of pediatric solid tumors.

Authors:  Rachael L Terry; Deborah Meyran; David S Ziegler; Michelle Haber; Paul G Ekert; Joseph A Trapani; Paul J Neeson
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

Review 6.  Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.

Authors:  Xinjie Bao; Xiangyi Kong; Chengxian Yang; Huanwen Wu; Wenbin Ma; Renzhi Wang
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

7.  Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1.

Authors:  In Kyung Hwang; Seung Min Hahn; Hyo Sun Kim; Sang Kyum Kim; Hyo Song Kim; Kyoo-Ho Shin; Chang Ok Suh; Chuhl Joo Lyu; Jung Woo Han
Journal:  Cancer Res Treat       Date:  2016-12-01       Impact factor: 4.679

8.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

9.  Giant malignant peripheral nerve sheath tumor of thigh in an adolescent with neurofibromatosis type 1: a case report.

Authors:  Hacı Bayram Tosun; Sancar Serbest; Bilge Aydın Turk; Seyit Ali Gumustas; Abuzer Uludag
Journal:  Int Med Case Rep J       Date:  2015-10-28

10.  Prognosis and risk factors for malignant peripheral nerve sheath tumor: a systematic review and meta-analysis.

Authors:  Zhenyu Cai; Xiaodong Tang; Haijie Liang; Rongli Yang; Taiqiang Yan; Wei Guo
Journal:  World J Surg Oncol       Date:  2020-09-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.